One of my PhD candidates is presenting her research results as a Vignette Presentation at HTAi 2017 that is held in Rome, Italy. The title of her presentation is "Health Technology Assessment in Japan: Current Issues and Challenges." As you know, the trial evaluation of HTA for approved pharmaceuticals in Japan is currently conducting and the government plans to introduce HTA officially in 2018. This policy will effect on various stakeholders and influence on many aspects. If you participate HTAi 2017, Rome and are interested in this topic, please come to the session and discuss with her.